J7303 — Contraceptive supply, hormone containing vaginal ring, each
J7303 is a HCPCS Level II code for contraceptive supply, hormone containing vaginal ring, each. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2021 and is not valid on new claims.
This code has been terminated
CMS terminated J7303 on September 30, 2021. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Non-covered by statute
Excluded from coverage by the Social Security Act itself, not by a policy decision. No documentation and no appeal changes this one — an ABN is the relevant conversation.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J7303
- Long descriptor
- Contraceptive supply, hormone containing vaginal ring, each
- Short descriptor
- Contraceptive vaginal ring
- Added
- January 1, 2004
- Terminated
- September 30, 2021
- BETOS
- Z2
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to J7303
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7303 is not quite right, the correct code is very often within a few positions of it.
- J7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
- J7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
- J7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
- J7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
- J7299Intrauterine copper contraceptive (miudella)
- J7300Intrauterine copper contraceptive (paragard)
- J7301Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302Levonorgestrel-releasing intrauterine contraceptive system, 52 mgterminated
- J7304Contraceptive supply, hormone containing patch, each
- J7306Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gramterminated
- J7310Ganciclovir, 4.5 mg, long-acting implantterminated
- J7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
Questions about J7303
What is HCPCS code J7303?
J7303 is a HCPCS Level II code for contraceptive supply, hormone containing vaginal ring, each. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7303?
The CMS HCPCS file marks J7303 as "Non-covered by statute". Excluded from coverage by the Social Security Act itself, not by a policy decision. No documentation and no appeal changes this one — an ABN is the relevant conversation.
Is J7303 still valid?
No. J7303 was terminated on September 30, 2021 and should not be used on new claims.